Abstract
Fibroblast growth factor-23 (FGF23) is central to phosphate homeostasis. The author examined if blood levels of FGF23 allow discrimination of classic hypophosphatemic rickets from other causes of non-nutritional rickets with hypophosphatemia. Forty-two children (median age: 102 mo) with non-nutritional rickets and hypophosphatemia were clinically classified as having distal renal tubular acidosis (RTA, n = 12), Fanconi syndrome (n = 8), classic hypophosphatemic rickets (n = 11), vitamin D dependent rickets (n = 7) and Dent disease (n = 4). Median blood FGF23 (measured by C-terminal ELISA) concentrations were similar in all groups (P = 0.24). These levels did not correlate with phosphate, tubular maximum for phosphate, calcium, 25-hydroxyvitamin D, creatinine, and parathormone levels. Patients with distal RTA showed variable degree of proximal tubular dysfunction that resolved following alkali supplements. Blood FGF23 levels did not satisfactorily differentiate classic hypophosphatemic rickets from other causes of hypophosphatemic rickets.
This is a preview of subscription content, log in via an institution to check access.
References
Carpenter TO. The expanding family of hypophosphatemic syndromes. J Bone Miner Metab. 2012;30:1–9.
McMillan JA. Oski’s pediatrics: principles & practice. Philadelphia: Lippincott Williams & Wilkins; 2006. p. 2623.
Walton RJ, Bijvoet OL. Nomogram for derivation of renal threshold phosphate concentration. Lancet. 1975;2:309–10.
Jonsson KB, Zahradnik R, Larsson T, et al. Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia. N Engl J Med. 2003;348:1656–63.
Gifre L, Martínez de Osaba MJ, Monegal A, Guañabens N, Peris P. Clinical usefulness of the determination of fibroblast growth factor 23 in the evaluation of patients with osteomalacia. Med Clin (Barc). 2014;42:447–50.
Endo I, Fukumoto S, Ozono K, et al. Clinical usefulness of measurement of fibroblast growth factor 23 (FGF23) in hypophosphatemic patients: proposal of diagnostic criteria using FGF23 measurement. Bone. 2008;42:1235–9.
Braithwaite V, Jones KS, Assar S, Schoenmakers I, Prentice A. Predictors of intact and C-terminal fibroblast growth factor 23 in Gambian children. Endocr Connect. 2014;3:1–10.
Prentice A, Ceesay M, Nigdikar S, Allen SJ, Pettifor JM. FGF23 is elevated in Gambian children with rickets. Bone. 2008;42:788–97.
Braithwaite V, Jarjou LMA, Goldberg GR, Prentice A. Iron status and fibroblast growth factor-23 in Gambian children. Bone. 2012;50:1351–6.
Tasic V, Korneti P, Gucev Z, Hoppe B, Blau N, Cheong HI. Atypical presentation of distal renal tubularacidosis in two siblings. Pediatr Nephrol. 2008;23:1177–81.
Author information
Authors and Affiliations
Contributions
JB: Patient care, data collection and manuscript preparation; DB: Laboratory work for the study; PK: Patient care and manuscript preparation; NG: Patient care and laboratory work for the study; AS and PH: Patient care; RK: Patient care and data collection; AB: Study design, patient care and manuscript preparation. AB is the guarantor for this paper.
Corresponding author
Ethics declarations
Conflict of Interest
None.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Bharati, J., Bhatia, D., Khandelwal, P. et al. C-Terminal Fibroblast Growth Factor-23 Levels in Non-Nutritional Hypophosphatemic Rickets. Indian J Pediatr 86, 555–557 (2019). https://doi.org/10.1007/s12098-019-02909-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12098-019-02909-4